Literature DB >> 24256642

Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.

Robert P Myers1, Puneeta Tandon, Michael Ney, Glenda Meeberg, Peter Faris, Abdel Aziz M Shaheen, Alexander I Aspinall, Kelly W Burak.   

Abstract

BACKGROUND: Modifications to the Model for End-Stage Liver Disease (MELD) have been proposed to improve prioritization of liver transplant (LT) candidates. Using a U.S. database, we derived a revised MELD including sodium and albumin [5-variable MELD (5vMELD)] that improved prediction of waiting list mortality. Our objectives were to confirm the association between hypoalbuminaemia and mortality and to externally validate 5vMELD in Canadian LT candidates.
METHODS: Among adults registered on the LT waiting list at the University of Alberta (01/2000-10/2009), Cox regression determined the association between albumin and 1-year waiting list mortality. The discrimination of MELD, MELDNa and 5vMELD for predicting 1-year mortality were compared using c-statistics.
RESULTS: Among 677 patients, 17% died and 51% underwent LT within 1 year of listing. Median serum albumin was 3.1 g/dl (IQR 2.6-3.6) and 70% of patients were hypoalbuminaemic (albumin <3.5 g/dl). One-year mortality in patients with normal serum albumin and hypoalbuminaemia were 14% and 29% respectively (P = 0.004). For patients with serum albumin between 2.0 and 4.0 g/dl, an approximately linear, inverse relationship was observed between albumin and 1-year mortality [adjusted hazard ratio (HR) 1.45; 95% CI 1.03-2.03; P = 0.03]. For this outcome, the c-statistic of 5vMELD (0.778) was superior to those of MELD (0.754) and MELDNa (0.765) (both P ≤ 0.05).
CONCLUSIONS: Hypoalbuminaemia is an independent predictor of mortality on the LT waiting list. Compared with MELD and MELDNa, 5vMELD improves prediction of mortality suggesting that modification of these scores to include serum albumin should be considered as a means of prioritizing LT candidates.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  MELD; MELDNa; discrimination; liver transplantation; mortality; outcomes

Mesh:

Substances:

Year:  2013        PMID: 24256642     DOI: 10.1111/liv.12373

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

1.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

Authors:  Shiv Kumar Sarin; Chandan Kumar Kedarisetty; Zaigham Abbas; Deepak Amarapurkar; Chhagan Bihari; Albert C Chan; Yogesh Kumar Chawla; A Kadir Dokmeci; Hitendra Garg; Hasmik Ghazinyan; Saeed Hamid; Dong Joon Kim; Piyawat Komolmit; Suman Lata; Guan Huei Lee; Laurentius A Lesmana; Mamun Mahtab; Rakhi Maiwall; Richard Moreau; Qin Ning; Viniyendra Pamecha; Diana Alcantara Payawal; Archana Rastogi; Salimur Rahman; Mohamed Rela; Anoop Saraya; Didier Samuel; Vivek Saraswat; Samir Shah; Gamal Shiha; Brajesh Chander Sharma; Manoj Kumar Sharma; Kapil Sharma; Amna Subhan Butt; Soek Siam Tan; Chitranshu Vashishtha; Zeeshan Ahmed Wani; Man-Fung Yuen; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2014-09-26       Impact factor: 6.047

2.  Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative data.

Authors:  Bolin Niu; Kimberly A Forde; David S Goldberg
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-10-21       Impact factor: 2.890

3.  Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.

Authors:  Allison J Kwong; Jennifer C Lai; Jennifer L Dodge; John P Roberts
Journal:  Liver Transpl       Date:  2015-11       Impact factor: 5.799

Review 4.  A Comprehensive Review of Outcome Predictors in Low MELD Patients.

Authors:  Nikhilesh R Mazumder; Kofi Atiemo; Matthew Kappus; Giuseppe Cullaro; Matthew E Harinstein; Daniela Ladner; Elizabeth Verna; Jennifer Lai; Josh Levitsky
Journal:  Transplantation       Date:  2020-02       Impact factor: 5.385

5.  Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis.

Authors:  Aldo J Montano-Loza; Andres Duarte-Rojo; Judith Meza-Junco; Vickie E Baracos; Michael B Sawyer; Jack X Q Pang; Crystal Beaumont; Nina Esfandiari; Robert P Myers
Journal:  Clin Transl Gastroenterol       Date:  2015-07-16       Impact factor: 4.488

6.  Comparison of risk adjustment methods in patients with liver disease using electronic medical record data.

Authors:  Yuan Xu; Ning Li; Mingshan Lu; Elijah Dixon; Robert P Myers; Rachel J Jolley; Hude Quan
Journal:  BMC Gastroenterol       Date:  2017-01-07       Impact factor: 3.067

7.  Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry.

Authors:  Qi Ling; Haojiang Dai; Runzhou Zhuang; Tian Shen; Weilin Wang; Xiao Xu; Shusen Zheng
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

8.  Comorbidities and Outcome of Alcoholic and Non-Alcoholic Liver Cirrhosis in Taiwan: A Population-Based Study.

Authors:  Tzu-Wei Yang; Chi-Chih Wang; Ming-Chang Tsai; Yao-Tung Wang; Ming-Hseng Tseng; Chun-Che Lin
Journal:  Int J Environ Res Public Health       Date:  2020-04-20       Impact factor: 3.390

9.  Factors associated with waiting time on the liver transplant list: an analysis of the United Network for Organ Sharing (UNOS) database.

Authors:  Judy A Trieu; Mohammad Bilal; Bashar Hmoud
Journal:  Ann Gastroenterol       Date:  2017-11-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.